关注
Cinnamon L. Hardee, Ph.D.
Cinnamon L. Hardee, Ph.D.
在 bcm.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Advances in non-viral DNA vectors for gene therapy
CL Hardee, LM Arévalo-Soliz, BD Hornstein, L Zechiedrich
Genes 8 (2), 65, 2017
3852017
Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy
SN De Oliveira, C Ryan, F Giannoni, CL Hardee, I Tremcinska, ...
Human gene therapy 24 (10), 824-839, 2013
1092013
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells
F Giannoni, CL Hardee, J Wherley, E Gschweng, S Senadheera, ...
Molecular Therapy 21 (5), 1044-1054, 2013
792013
CD4+ CD25− T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in …
A Chhabra, L Yang, P Wang, B Comin-Anduix, R Das, NG Chakraborty, ...
The Journal of Immunology 181 (2), 1063-1070, 2008
592008
Dosing and re-administration of lentiviral vector for in vivo gene therapy in rhesus monkeys and ADA-deficient mice
DA Carbonaro-Sarracino, AF Tarantal, CCI Lee, ML Kaufman, S Wandro, ...
Molecular Therapy-Methods & Clinical Development 16, 78-93, 2020
132020
Effects of vector backbone and pseudotype on lentiviral vector-mediated gene transfer: studies in infant ADA-deficient mice and rhesus monkeys
DC Sarracino, AF Tarantal, CCI Lee, M Martinez, X Jin, X Wang, ...
Molecular Therapy 22 (10), 1803-1816, 2014
112014
Improving therapeutic potential of non-viral minimized DNA vectors
LM Arévalo-Soliz, CL Hardee, JM Fogg, NR Corman, C Noorbakhsh, ...
Cell & gene therapy insights 6 (10), 1489, 2020
102020
Lentiviral vectors with amplified β cell-specific gene expression
KL Shaw, E Pais, S Ge, C Hardee, D Skelton, RP Hollis, GM Crooks, ...
Gene therapy 16 (8), 998-1008, 2009
102009
Regulated expansion of human pancreatic β-cells
E Pais, J Park, T Alexy, V Nikolian, S Ge, K Shaw, S Senadheera, ...
Molecular Therapy 18 (7), 1389-1396, 2010
62010
466. Attenuated CTLA-4 Inhibition in CD19-Targeted T Cells Expressing a Second-Generation CD28-Based Chimeric Antigen Receptor
F Giannoni, CL Hardee, J Wherley, IB Bahner, R Hollis, V Gersuk, X Wang, ...
Molecular Therapy 20, 1, 2012
12012
Generation of Antigen Specific T Cells from Human Hematopoietic Stem/Progenitor Cells (HSPC) Transduced with the cDNA for a T Cell Receptor Specific for the MART-1 Antigen
F Giannoni, CL Hardee, J Wherley, IB Bahner, R Hollis, V Gersuk, X Wang, ...
MOLECULAR THERAPY 20, S181-S181, 2012
2012
Gene Transfer to Hematopoietic Stem/Progenitor Cells As a Novel Approach for Immunotherapy Against B-Lineage Malignancies: In Vivo Xenograft Model
SN De Oliveira, F Giannoni, C Hardee, A Sahaghian, LJN Cooper, ...
Blood, The Journal of the American Society of Hematology 118 (21), 4168-4168, 2011
2011
Lentiviral Vector-Mediated Gene Transfer In Vivo in Adenosine Deaminase (ADA)-Deficient Mice and Rhesus Monkeys: Effects of Vector Backbone and Pseudotype
DA Carbonaro, AF Tarental, CCI Lee, RP Hollis, DC Skelton, C Hardee, ...
MOLECULAR THERAPY 17, S11-S11, 2009
2009
Lentiviral Vector Designed To Induce the Controlled Expansion of Pancreatic Beta Cells
E Pais, J Park, S Ge, K Shaw, S Senadheera, CL Hardee, DC Skelton, ...
MOLECULAR THERAPY 17, S296-S296, 2009
2009
系统目前无法执行此操作,请稍后再试。
文章 1–14